检索结果 - Ho‐Jin Shin

Refine Results
  1. 1
    Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA

    Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA 由 HoJin Shin, Sebastian Schneeweiß, Robert J. Glynn, Elisabetta Patorno

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells

    Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells 由 Ho‐Jin Shin, Jeanette Baker, Dennis B. Leveson-Gower, Aaron T. Smith, Emanuela Sega, Robert S. Negrin

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy

    Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy 由 Gyung Hyuck Ko, Joo-Seop Chung, Y.-M. Seol, S.-G. Kim, Ho‐Jin Shin, Young Jin Choi, G.-J. Cho, Dong Hun Shin

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma

    Prognostic value of metabolic tumor volume on PET / CT in primary gastrointestinal diffuse large B cell lymphoma 由 Gyung Hyuck Ko, Joo Seop Chung, Ho‐Jin Shin, Joon‐Ho Moon, Jeong-Ok Lee, Ho Sup Lee, Sang‐Min Lee, Gyeong-Won Lee, Suee Lee, Seong‐Jang Kim

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement

    Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement 由 Gyung Hyuck Ko, Joo-Seop Chung, Ho‐Jin Shin, Sang‐Min Lee, Suee Lee, Ho Sup Lee, Gyeong‐Won Lee, Seong‐Jang Kim, Seok-Mo Lee, Chung Dong-Seop

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Safety and efficacy of BAY 94‐9027, a prolonged‐half‐life factor VIII

    Safety and efficacy of BAY 94‐9027, a prolonged‐half‐life factor VIII 由 Mark T. Reding, Hannah Jia Hui Ng, Lone Hvitfeldt Poulsen, M. Elaine Eyster, Ingrid Pabinger, Ho‐Jin Shin, R. Walsch, Michael M. Lederman, M. Wang, Marion Hardtke, Lisa A. Michaels

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    SUNMO: A Phase III Trial Evaluating the Efficacy and Safety of Mosunetuzumab in Combination with Polatuzumab Vedotin Versus Rituximab in Combination with Gemcitabine Plus Oxaliplatin in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

    SUNMO: A Phase III Trial Evaluating the Efficacy and Safety of Mosunetuzumab in Combination with Polatuzumab Vedotin Versus Rituximab in Combination with Gemcitabine Plus Oxaliplat... 由 Jason R. Westin, Adam J. Olszewski, Laura Fogliatto, Won-Seog Kim, Ho‐Jin Shin, Hao Wu, Shen Yin, Song Pham, Elicia Penuel, Jing Jing, Michael C. Wei, Lihua E. Budde

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma

    Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma 由 Gyung Hyuck Ko, Joo Seop Chung, Je‐Jung Lee, Shin Young Jeong, Sang‐Min Lee, Junshik Hong, Ari Chong, Joon‐Ho Moon, Ji‐Hyun Kim, Seok‐Mo Lee, Seong‐Jang Kim, Ho‐Jin Shin

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome

    Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelod... 由 Kyoo‐Hyung Lee, Je‐Hwan Lee, Jung‐Hee Lee, Dae‐Young Kim, Miee Seol, Young‐Shin Lee, Young-Ah Kang, Mijin Jeon, Hyun‐Ju Hwang, Ahrang Jung, Sung‐Han Kim, Sung‐Cheol Yun, Ho‐Jin Shin

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy

    Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy 由 Young Mi Seol, Bo Ran Kwon, Gyung Hyuck Ko, Young Jin Choi, Ho Jin Shin, Joo Seop Chung, Goon Jae Cho, Jin Chun Lee, Byung‐Joo Lee, Soo Geun Wang, Hak Jin Kim, Won Taek Kim, Seung Jang Kim, Eun Young Yun

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    SUNMO: PHASE III TRIAL OF MOSUNETUZUMAB PLUS POLATUZUMAB VEDOTIN VERSUS RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN IN RELAPSED/REFRACTORY AGGRESSIVE NON‐HODGKIN LYMPHOMA

    SUNMO: PHASE III TRIAL OF MOSUNETUZUMAB PLUS POLATUZUMAB VEDOTIN VERSUS RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN IN RELAPSED/REFRACTORY AGGRESSIVE NON‐HODGKIN LYMPHOMA 由 Astrid Pavlovsky, Jason R. Westin, Adam J. Olszewski, Laura Fogliatto, W. S. Kim, Ho‐Jin Shin, Dryelle Oliveira Dias Leão, Young‐Woo Jeon, Lalita Norasetthada, Eduardo Magalhães Rego, Hao Wu, Shengli Yin, Connie Lee Batlevi, S. Pham, E. Penuel, Jing Jie, M. C. Wei, Lihua E. Budde

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma

    Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma 由 Soo Chin Ng, Joon‐Ho Moon, Sung Soo Park, Youngil Koh, Ji Hyun Lee, Hyeon‐Seok Eom, Ho‐Jin Shin, Sung Hoon Jung, Young Rok, Gilbert Wilfred, Azlan Husin, Hyo Jung Kim, S A W Fadilah, Myung-Won Lee, Hye-won Heo, Kihyun Kım, Suporn Chuncharunee

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Hematologic and molecular responses to ropeginterferon alfa‐2b therapy of polycythemia vera: 48‐week results from a prospective study

    Hematologic and molecular responses to ropeginterferon alfa‐2b therapy of polycythemia vera: 48‐week results from a prospective study 由 Seug Yun Yoon, Sung‐Soo Yoon, Deok‐Hwan Yang, Gyeong‐Won Lee, Sang Kyun Sohn, Ho‐Jin Shin, Sung Hwa Bae, Chul Won Choi, Eun‐Ji Choi, June‐Won Cheong, Soo‐Mee Bang, Joon Seong Park, Suk Joong Oh, Yong Park, Young Hoon Park, Sung‐Eun Lee

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Efficacy of Daratumumab in Combination with Standard of Care Regimens in Lenalidomide-Exposed or -Refractory Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Analysis of the Castor, Pollux, and MMY1001 Studies

    Efficacy of Daratumumab in Combination with Standard of Care Regimens in Lenalidomide-Exposed or -Refractory Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Analysis of... 由 Saad Z. Usmani, María‐Victoria Mateos, Suzanne Lentzsch, Hang Quach, Marcelo Capra, Roberto Ovilla, Jae‐Cheol Jo, Ho‐Jin Shin, Pieter Sonneveld, Ming Qi, Himal Amin, Jianping Wang, Xiang Qin, Linda Okonkwo, Jon Ukropec, Sonali Trivedi, Kenshi Suzuki, Meletios Α. Dimopoulos, Michèle Cavo, Ajay K. Nooka, Ajai Chari, Thierry Façon

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma

    Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma 由 Yok‐Lam Kwong, Sung Joon Kim, Eric Tse, Sung Yong Oh, Jae‐Yong Kwak, Hyeon‐Seok Eom, Y.R. Do, Yeung‐Chul Mun, S. R. Lee, Ho‐Jin Shin, Cheolwon Suh, Shin Sung Chuang, Yung Seng Lee, Soon Thye Lim, Koji Izutsu, Ritsuro Suzuki, Thomas Relander, Francesco d’Amore, Norbert Schmitz, Arnaud Jaccard, W. S. Kim

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

    Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomiz... 由 Pau Montesinos, Gail J. Roboz, Claude‐Eric Bulabois, Marion Subklewe, Uwe Platzbecker, Yishai Ofran, Cristina Papayannidis, Agnieszka Wierzbowska, Ho Jin Shin, Vadim Doronin, Stefan Deneberg, Su-Peng Yeh, Mehmet Ali Özcan, Steven Knapper, Jorge E. Cortés, Daniel A. Pollyea, Gert J. Ossenkoppele, Sergio Giralt, Hartmut Döhner, Michael Heuser, Liang Xiu, Indrajeet Singh, Fei Huang, Julie S. Larsen, Andrew H. Wei

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis

    Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo... 由 Naveen Pemmaraju, Adam J. Mead, Tim C. P. Somervaille, James McCloskey, Francesca Palandri, Steffen Koschmieder, David Lavie, Brian Leber, Su‐Peng Yeh, María Teresa Gómez‐Casares, Emanuele Ammatuna, Ho‐Jin Shin, Keita Kirito, Éric Jourdan, Timothy Devos, Hun Chuah, Atanas Radinoff, Andrija Bogdanović, Rastislav Moskal, Qi Jiang, Avijeet Chopra, Elektra J. Papadopoulos, Jalaja Potluri, Francesco Passamonti

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)

    Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) 由 Yu Ri Kim, Jin Seok Kim, Yoo Hong Min, Dok Hyun Yoon, Ho‐Jin Shin, Yeung‐Chul Mun, Yong Park, Young Rok, Seong Hyun Jeong, Joon Seong Park, Sung Yong Oh, Suee Lee, Eunkyung Park, Joung-Soon Jang, Won Sik Lee, Hwe-Won Lee, Hyeon‐Seok Eom, Jae‐Sook Ahn, Jae-Heon Jeong, Sun Kyung Baek, Seok Jin Kim, Won Seog Kim, Cheolwon Suh

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

    Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia 由 Jae-Yong Kwak, Sung‐Hyun Kim, Suk Joong Oh, Dae Young Zang, Hawk Kim, Jeong‐A Kim, Young Rok, Hyeoung Joon Kim, Joon Seong Park, Chul Won Choi, Won Sik Lee, Yeung‐Chul Mun, Jee Hyun Kong, Joo Seop Chung, Ho‐Jin Shin, Dae‐Young Kim, Jinny Park, Chul Won Jung, Udomsak Bunworasate, Narcisa Sonia Comia, Saengsuree Jootar, Arry Harryanto Reksodiputro, Priscilla B. Caguioa, Sung‐Eun Lee, Dong‐Wook Kim

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

    Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial 由 Yuqin Song, Hervé Tilly, Shinya Rai, Huilai Zhang, Jie Jin, Hideki Goto, Yasuhito Terui, Ho‐Jin Shin, Won Seog Kim, Junning Cao, Jifeng Feng, Hyeon‐Seok Eom, Tae Min Kim, Cheng‐Hong Tsai, Jyh‐Pyng Gau, Hideo Koh, Liling Zhang, Yongping Song, Yu Yang, Wei Li, He Huang, Kiyoshi Ando, Jeff P. Sharman, Laurie H. Sehn, Lilian Bu, Xin Wang, Yanwen Jiang, Jamie Hirata, Calvin Lee, Jun Zhu, Koji Izutsu

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: